S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
Penny Stock Shows Big Potential (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Penny Stock Shows Big Potential (Ad)
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Penny Stock Shows Big Potential (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
Penny Stock Shows Big Potential (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Penny Stock Shows Big Potential (Ad)
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Penny Stock Shows Big Potential (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
Penny Stock Shows Big Potential (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Penny Stock Shows Big Potential (Ad)
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Penny Stock Shows Big Potential (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
Penny Stock Shows Big Potential (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Penny Stock Shows Big Potential (Ad)
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Penny Stock Shows Big Potential (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
NASDAQ:NH

NantHealth - NH Stock Forecast, Price & News

$1.87
+0.26 (+16.11%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.65
$1.87
50-Day Range
$1.61
$3.86
52-Week Range
$1.57
$13.05
Volume
3,468 shs
Average Volume
9,538 shs
Market Capitalization
$14.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NH stock logo

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Morrisville, NC.

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

NantHealth (NASDAQ:NH) Now Covered by Analysts at StockNews.com
Penny Stock Shows Big Potential
The $4.37 trillion wellness market and the little-known penny stock to get on radar now.
Penny Stock Shows Big Potential
The $4.37 trillion wellness market and the little-known penny stock to get on radar now.
NantHealth Announces 1-for-15 Reverse Stock Split
NantHealth Reports 2022 Third Quarter Financial Results
NantHealth, Inc. (NASDAQ: NH)
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript
See More Headlines
Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings
11/04/2021
Today
3/21/2023
Next Earnings (Estimated)
3/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
326
Year Founded
N/A

Profitability

Net Income
$-58,260,000.00
Pretax Margin
-89.67%

Debt

Sales & Book Value

Annual Sales
$62.65 million
Book Value
($21.04) per share

Miscellaneous

Free Float
2,983,000
Market Cap
$14.44 million
Optionable
Optionable
Beta
1.86

Key Executives

  • Patrick Soon-ShiongPatrick Soon-Shiong
    Chairman & Chief Executive Officer
  • Ronald Allen LouksRonald Allen Louks
    Chief Operating Officer
  • Bob Petrou
    Chief Financial Officer
  • Tiffany Avery
    Chief Medical Officer
  • Brandon Villery
    Secretary, Senior VP-Legal, VP & General Counsel













NH Stock - Frequently Asked Questions

How have NH shares performed in 2023?

NantHealth's stock was trading at $3.65 at the beginning of the year. Since then, NH shares have decreased by 48.7% and is now trading at $1.8735.
View the best growth stocks for 2023 here
.

Are investors shorting NantHealth?

NantHealth saw a increase in short interest in February. As of February 28th, there was short interest totaling 51,000 shares, an increase of 17.5% from the February 13th total of 43,400 shares. Based on an average trading volume of 104,100 shares, the short-interest ratio is currently 0.5 days. Currently, 2.0% of the company's stock are short sold.
View NantHealth's Short Interest
.

When is NantHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our NH earnings forecast
.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) released its earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The business earned $14.36 million during the quarter, compared to analysts' expectations of $17.70 million. During the same period in the prior year, the company posted ($0.08) EPS.

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

Who are NantHealth's major shareholders?

NantHealth's stock is owned by a number of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.35%), Millennium Management LLC (0.13%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends
.

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $1.87.

How much money does NantHealth make?

NantHealth (NASDAQ:NH) has a market capitalization of $14.44 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($7.6462) on an earnings per share basis.

How many employees does NantHealth have?

The company employs 326 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 3/21/2023 by MarketBeat.com Staff